Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations ...

Buying stock in great companies when they are dealing with some short-term issue that creates stock price weakness can set ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

Some on Wall Street now advise selling any rally in U.S. markets. However, these four high-yield dividend stocks are keepers.

Public health leaders looked to UNC-Chapel Hill virologist Ralph Baric to end the pandemic. Their critics blamed it on him.